Claire Brown
InvestorPartner at Oxford Science Enterprises
Oxford, United Kingdom
Writes $100K β $5M checks Β· typically $1.5M
Find your path to Claire
519 people in our graph share verified history with Claire β schools, employers, funds. One of them is your warm intro.
Ben PerryunlockedClaire: together at UCB Research Inc (2003β2004)
Claire: together at CFA Institute
Γ2Claire: together at AstraZeneca
Γ4Claire: together at Loughborough University
About
Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
ContactΒ· self-published, not guessed
Invests in
Biotech
Experience
- Oxford Science EnterprisesPartnercurrent2020 β presentOxford, England, United Kingdom
- Acionna TherapeuticsBoard of Directorscurrent2025 β present
- Scripta TherapeuticsBoard of Directorscurrent2025 β present
- Thelior BioBoard Directorcurrent2025 β present
- T-Cypher BioBoard Directorcurrent2021 β presentOxford, England, United Kingdom
- AlveoGeneBoard Directorcurrent2023 β present
- Orfonyx BioBoard Directorcurrent2022 β present
- Nucleome TherapeuticsBoard Observercurrent2023 β present
- OMass TherapeuticsBoard Observer2021 β 2024
- Dark Blue TherapeuticsBoard Director2020 β 2023Oxford, England, United Kingdom
- AlethiomicsBoard Director2022 β 2023
- Kinomica LimitedBoard Of Directors2019 β 2021London and Manchester, UK
- Pioneer GroupHead of Investment2015 β 2021Alderley Park
- NanoSyrinxBoard of Directors2020Warwick, England, United Kingdom
- Rinri Therapeutics Ltd.Board Of Directors2019 β 2020Sheffield, UK
- AstraZenecaDirector, Strategy, Business Development and Investment2007 β 2015UK
- Sanofi GenzymePrincipal Scientist, Pharmacology & Toxicology2004 β 2007USA
- UCB Research IncPharmacology Dept, Principal Scientist2000 β 2004
Skills & more
Drug Development9Life Sciences23Biotechnology21Drug Discovery15Pharmacology7R&D16
- Investment Management Certificate β CFA Institute
- Role of the Board β Institute of Directors (IoD)
From Claire's professional profile.
Colleagues at Oxford Science Enterprises
Alex Hammacher
Head of Strategic Operations & Corporate Finance at Oxford Science Enterprises
Alexandra Riozzi
Executive Assistant at Oxford Science Enterprises
Alicia Mederick
Team Co-ordinator at Oxford Science Enterprises
Alma Simangunsong
People Apprentice at Oxford Science Enterprises
Andre Crawford-Brunt
Non-Executive Director at Oxford Science Enterprises
Andrew Straiton
Senior Associate, Deep Tech at Oxford Science Enterprises
Andy Penfold
Content Lead at Oxford Science Enterprises
Antonia Jenkinson
Chief Financial Officer at Oxford Science Enterprises
Network3
Lilly Bussmann
Partner at Oxford Science Enterprises
Martin Fiennes
Advisor, Deep Tech at Oxford Science Enterprises
Nicholas Dixon-Clegg
Partner, Head of Independent Investments at Oxford Science Enterprises
Investors connected to Claire in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Claire Brown?
- Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
- Where does Claire Brown work?
- Claire Brown is Partner at Oxford Science Enterprises.
- What does Claire Brown invest in?
- Claire Brown invests in Biotech.
- What check size does Claire Brown write?
- Claire Brown typically writes checks of $100K β $5M.
- Where did Claire Brown go to school?
- Claire Brown studied at University of Glasgow (BSc (Hons), Physiology); Glasgow Caledonian University (Ph.D, Pharmacology); Loughborough University (MBA, Business Administration and Management).
Same school
Also attended University of Glasgow127
Andreas SchropferHead of Finance at Brighteye VenturesSarah MandersonLegal Director at Hoxton VenturesKelsey BolanderAssociate β Business Ops & Partner Support at Energize VenturesRob DesboroughGeneral Partner and Chair of Seraphim Space Accelerator at Seraphim SpaceAida KhalilProgramme Associate at Seraphim SpaceNatalie JohnstonInvestment Principal at 4BIO Capital
+ 121 more
Also attended Glasgow Caledonian University19
Costanza CariniInvestor at DN CapitalLynn HallCommunications Manager at Kelvin CapitalKerry SharpChief Finance & Investment Officer at Scottish Venture FundPhemelo MabuseResearch Analyst at InjiniKaran DarrochPartner at MML UK AdvisorKai RintalaManaging Director, Taaleri Energia at Taaleri Energia Funds
+ 13 more
Also attended Loughborough University110
Abbie RobusAssociate Director at Mayfair Equity PartnersDiane WalkerHead of Group Finance & Operations at Mayfair Equity PartnersCostanza CariniInvestor at DN CapitalJoe HalliwellClient Team Member at Generation Investment ManagementAlasdair MitchellPortfolio Support at Giant Ventures Global LlpTom WigmoreFinancial Accountant at Advent Life Sciences
+ 104 more
Also attended CFA Institute242
Matt CherianVenture Partner at Monta Vista CapitalLaviva MazharPrincipal at Luge CapitalJan AvontsInvestment Director at Capricorn Venture PartnersKim RobertsonFinancial Manager at 4Di CapitalHans DellenbachSenior Partner, CFO, Head of Corporate Development at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag
+ 236 more





























































